New hope for young blood cancer patients: supercharged cord blood transplants show promise
Disease control
Completed
This study tested a new method to improve cord blood transplants for children and young adults (under 21) with very high-risk blood cancers like leukemia. Researchers used a molecule called UM171 to 'expand' or grow more cells from a cord blood donation before transplant, aiming …
Phase: PHASE1, PHASE2 • Sponsor: ExCellThera inc. • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC